1. Home
  2. CECO vs TRVI Comparison

CECO vs TRVI Comparison

Compare CECO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

HOLD

Current Price

$59.51

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.20

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CECO
TRVI
Founded
1966
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CECO
TRVI
Price
$59.51
$14.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$47.50
$20.59
AVG Volume (30 Days)
302.2K
2.3M
Earning Date
10-28-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
334.15
N/A
EPS
1.43
N/A
Revenue
$718,253,000.00
N/A
Revenue This Year
$39.58
N/A
Revenue Next Year
$14.60
N/A
P/E Ratio
$41.72
N/A
Revenue Growth
29.86
N/A
52 Week Low
$17.57
$2.36
52 Week High
$59.95
$14.39

Technical Indicators

Market Signals
Indicator
CECO
TRVI
Relative Strength Index (RSI) 71.31 70.22
Support Level $54.27 $12.85
Resistance Level $56.60 $14.00
Average True Range (ATR) 2.25 0.85
MACD 0.79 0.08
Stochastic Oscillator 95.33 91.22

Price Performance

Historical Comparison
CECO
TRVI

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: